Skip to main content
. 2022 Jan 27;14(3):636. doi: 10.3390/cancers14030636

Figure 4.

Figure 4

The prognostic value of CD8+ TILs. Meta-analyses of time-to-event data indicated a favorable overall survival (OS) and disease-free survival (DFS) for patients with high pretherapeutic CD8+ TILs density. HR: Hazard Ratio.